209 related articles for article (PubMed ID: 16340778)
21. Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study.
Matsumura A; Miyazaki T; Tachibana T; Ando T; Koyama M; Koyama S; Ishii Y; Takahashi H; Nakajima Y; Numata A; Yamamoto W; Motohashi K; Hagihara M; Matsumoto K; Fujisawa S; Nakajima H
Turk J Haematol; 2020 Feb; 37(1):20-29. PubMed ID: 31464120
[TBL] [Abstract][Full Text] [Related]
22. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Cesaro S; Pillon M; Talenti E; Toffolutti T; Calore E; Tridello G; Strugo L; Destro R; Gazzola MV; Varotto S; Errigo G; Carli M; Zanesco L; Messina C
Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
[TBL] [Abstract][Full Text] [Related]
23. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
Roeker LE; Kim HT; Glotzbecker B; Nageshwar P; Nikiforow S; Koreth J; Armand P; Cutler C; Alyea EP; Antin JH; Richardson PG; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2019 Jan; 25(1):137-144. PubMed ID: 30081073
[TBL] [Abstract][Full Text] [Related]
24. Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation.
Mori T; Aisa Y; Shimizu T; Yamazaki R; Mihara A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Am J Hematol; 2007 Sep; 82(9):838-9. PubMed ID: 17506069
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.
Pihusch V; Pihusch M; Penovici M; Kolb HJ; Hiller E; Pihusch R
Thromb Res; 2005; 116(3):233-40. PubMed ID: 15935832
[TBL] [Abstract][Full Text] [Related]
26. Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy.
Sakaguchi H; Watanabe N; Muramatsu H; Doisaki S; Yoshida N; Matsumoto K; Kato K
Pediatr Blood Cancer; 2010 Dec; 55(6):1118-25. PubMed ID: 20589662
[TBL] [Abstract][Full Text] [Related]
27. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
Elbahlawan L; McArthur J; Quasney MW; Pei D; Srivastava K; Dahmer MK; Barfield R
J Pediatr Hematol Oncol; 2012 Apr; 34(3):175-9. PubMed ID: 22395218
[TBL] [Abstract][Full Text] [Related]
28. Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation.
Schneider V; Cabanillas Stanchi KM; Althaus K; Schober S; Michaelis S; Seitz C; Lang P; Handgretinger R; Bakchoul T; Hammer S; Döring M
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8443-8453. PubMed ID: 37086290
[TBL] [Abstract][Full Text] [Related]
29. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
Qureshi A; Marshall L; Lancaster D
Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
[TBL] [Abstract][Full Text] [Related]
30. Plasma brain natriuretic peptide is associated with hepatic veno-occlusive disease and early mortality after allogeneic hematopoietic stem cell transplantation.
Kataoka K; Nannya Y; Iwata H; Seo S; Kumano K; Takahashi T; Nagai R; Kurokawa M
Bone Marrow Transplant; 2010 Nov; 45(11):1631-7. PubMed ID: 20173786
[TBL] [Abstract][Full Text] [Related]
31. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.
Moscardó F; Sanz GF; de La Rubia J; Jiménez C; Saavedra S; Regadera A; Andreu R; García I; Plumé G; Martínez J; Martín G; Jarque I; Sanz MA
Bone Marrow Transplant; 2001 May; 27(9):983-8. PubMed ID: 11436110
[TBL] [Abstract][Full Text] [Related]
32. Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study.
Forrest DL; Thompson K; Dorcas VG; Couban SH; Pierce R
Bone Marrow Transplant; 2003 Jun; 31(12):1143-9. PubMed ID: 12796794
[TBL] [Abstract][Full Text] [Related]
33. The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan.
Lee CC; Chang HH; Lu MY; Yang YL; Chou SW; Lin DT; Jou ST; Yao M; Li CC; Yeh SP; Chen MH; Gau JP; Li SS; Wang PN; Liu YC; Wang TF; Tan TD; Lee MY; Yu MS; Wang CC; Lin SC; Chen YC; Su YC; Su KY; Lin KH
Ann Hematol; 2019 Mar; 98(3):745-752. PubMed ID: 30666432
[TBL] [Abstract][Full Text] [Related]
34. Busulfan clearance does not predict the development of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation.
Salman B; Al-Khabori M; Al-Huneini M; Al-Rawas A; Dennison D; Al-Za'abi M
Int J Hematol; 2020 Aug; 112(2):210-216. PubMed ID: 32468179
[TBL] [Abstract][Full Text] [Related]
35. Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?
Yoon JH; Min WS; Kim HJ; Kim JH; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Park CW
Bone Marrow Transplant; 2013 Nov; 48(12):1562-8. PubMed ID: 23892329
[TBL] [Abstract][Full Text] [Related]
36. [Efficiency of prevention and treatment of veno-occlusive disease of the liver after allogeneic stem cell transplantation].
Dong M; Lin Q; Wu XY
Ai Zheng; 2008 Jun; 27(6):646-9. PubMed ID: 18570742
[TBL] [Abstract][Full Text] [Related]
37. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.
Pihusch R; Salat C; Schmidt E; Göhring P; Pihusch M; Hiller E; Holler E; Kolb HJ
Transplantation; 2002 Nov; 74(9):1303-9. PubMed ID: 12451270
[TBL] [Abstract][Full Text] [Related]
38. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
39. High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients.
Myers KC; Lawrence J; Marsh RA; Davies SM; Jodele S
Biol Blood Marrow Transplant; 2013 Mar; 19(3):500-3. PubMed ID: 23211838
[TBL] [Abstract][Full Text] [Related]
40. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: Diagnosis, incidence, prophylaxis, and treatment.
Özkan HA; Özkan SG
Transfus Apher Sci; 2022 Feb; 61(1):103372. PubMed ID: 35101376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
